Abstract
A novel Pseudomonas aeruginosa lytic bacteriophage (phage), PA1Ø, was isolated, and its genome was sequenced completely. This phage is able to lyse not only P. aeruginosa but also Staphylococcus aureus. Genome analysis of PA1Ø showed that it is similar to a P. aeruginosa temperate phage, D3112, with the exception of the absence of a c repressor-encoding gene, which is known to play a critical role in the maintenance of the lysogenic state of D3112 in P. aeruginosa.
GENOME ANNOUNCEMENT
Lytic bacteriophages (phages) have been aimed at treating infectious bacterial diseases (7). Pseudomonas aeruginosa is one of the major life-threatening opportunistic pathogens that infect cystic fibrosis and immunocompromised patients. This Gram-negative bacterium can colonize various organs, including the lungs, kidneys, skin, and urinary tract, and cause inflammation and sepsis (4, 6, 15). Since P. aeruginosa is resistant to most antimicrobial agents and forms biofilms in organs, it is difficult to eliminate using traditional antimicrobial drugs. Recently, several clinical trials of phage therapy have been performed against P. aeruginosa-induced human and animal infections (8, 10). For therapeutic purposes, the phages should be obligatorily lytic and not harmful to humans or animals.
We report here a novel lytic P. aeruginosa phage, PA1Ø, which was isolated from sewage samples from a livestock farmhouse in South Korea. PA1Ø was amplified and purified by the agar overlay method using P. aeruginosa strain PAO1 as a propagating host. Further tests for determining the host range revealed that PA1Ø showed strong lytic activities against Gram-negative bacteria such as P. aeruginosa and Shigella sonnei and even against Gram-positive bacteria such as Staphylococcus aureus, Streptococcus salivarius, and Listeria monocytogenes (data not shown). This extraordinary ability of PA1Ø led us to determine the complete genome sequence of this phage.
Genomic DNA of PA1Ø was purified using a Qiagen Lambda midikit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Purified genomic DNA was fragmented by physical shearing, and fragmented DNAs were blunt end repaired and dephosphorylated for ligation with the pCB31 vector (Macrogen, Seoul, South Korea) to create a shotgun library. Ligated product was introduced into transformation-competent Escherichia coli DH10B cells; recovered plasmids were subjected to sequencing (ABI Prism 3730xl instrument; Applied Biosystems, Foster City, CA) to 8.52-fold coverage of the phage genome. Open reading frames (ORFs) were predicted by Glimmer version 3.0 (3), and genes were annotated by homology searches of the GenBank (1), COG (13), Swiss-Prot (5), and PIR protein databases (9).
The PA1Ø genome was found to be 34,553 bp in length, with 51 putative protein-coding genes with a G+C content of 64.8%. Among the ORFs identified, 40 were annotated as hypothetical proteins; homology searches identified transposase A, DNA transposition protein, host nuclease inhibitor protein, putative integral membrane protein, putative structural protein, portal protein, virion morphogenesis proteins, protease and scaffold proteins, putative major head subunit protein, and putative tail component protein. The PA1Ø genome is highly homologous to the genomes of phages MP29 (GenBank accession number EU272036.1) and 3112 (GenBank accession number AY394005.1), with identities of 93% and 90%, respectively. Both MP29 and D3112 are Pseudomonas phages belonging to the Siphoviridae family, indicating that PA1Ø is one of the Pseudomonas Siphoviridae phages. There have been no reports yet about MP29, but phage D3112 is a well-known lysogenic phage and has been used for molecular-biology studies of P. aeruginosa (2, 14). D3112 infects via the type IV pilus of P. aeruginosa (11). Consistent with this, PA1Ø also requires the type IV pilus for P. aeruginosa infection (data not shown). However, PA1Ø differs from D3112 by its lack of a c repressor-encoding gene. Since this gene is known to play a critical role in the maintenance of the lysogenic state of D3112 in P. aeruginosa (12), we are currently investigating whether the absence of a c repressor-encoding gene in PA1Ø is related to its strong lytic activity.
To our knowledge, PA1Ø is the first phage that can lyse both Gram-positive and Gram-negative bacteria. Characterization of PA1Ø may facilitate its development as a phage therapy and alternative antimicrobial agent applicable to the treatment of mixed bacterial infections with P. aeruginosa and S. aureus.
Nucleotide sequence accession number.
The whole-genome sequence of phage PA1Ø has been deposited in GenBank under accession no. HM624080.
ACKNOWLEDMENTS
This work was supported by a grant from the Korea Healthcare Technology R&D Project of the Ministry for Health, Welfare and Family Affairs, Republic of Korea (A084442), and in part by the Brain Korea 21 Project (2011).
REFERENCES
- 1. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW. 2011. GenBank. Nucleic Acids Res. 39:D32–D37 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Darzins A, Casadaban MJ. 1989. Mini-D3112 bacteriophage transposable elements for genetic analysis of Pseudomonas aeruginosa. J. Bacteriol. 171:3909–3916 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Delcher AL, Bratke KA, Powers EC, Salzberg SL. 2007. Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23:673–679 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Driscoll JA, Brody SL, Kollef MH. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351–368 [DOI] [PubMed] [Google Scholar]
- 5. Gasteiger E, Jung E, Bairoch A. 2001. SWISS-PROT: connecting biomolecular knowledge via a protein database. Curr. Issues Mol. Biol. 3:47–55 [PubMed] [Google Scholar]
- 6. Govan JR, Brown AR, Jones AM. 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2:153–164 [DOI] [PubMed] [Google Scholar]
- 7. Harper DR, Enright MC. 2011. Bacteriophages for the treatment of Pseudomonas aeruginosa infections. J. Appl. Microbiol. 111:1–7 [DOI] [PubMed] [Google Scholar]
- 8. Hawkins C, Harper D, Burch D, Anggard E, Soothill J. 2010. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet. Microbiol. 146:309–313 [DOI] [PubMed] [Google Scholar]
- 9. McGarvey PB, et al. 2000. PIR: a new resource for bioinformatics. Bioinformatics 16:290–291 [DOI] [PubMed] [Google Scholar]
- 10. Rhoads DD, et al. 2009. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial. J. Wound Care 18:237–238 [DOI] [PubMed] [Google Scholar]
- 11. Roncero C, Darzins A, Casadaban MJ. 1990. Pseudomonas aeruginosa transposable bacteriophages D3112 and B3 require pili and surface growth for adsorption. J. Bacteriol. 172:1899–1904 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Salmon KA, Freedman O, Ritchings BW, DuBow MS. 2000. Characterization of the lysogenic repressor (c) gene of the Pseudomonas aeruginosa transposable bacteriophage D3112. Virology 272:85–97 [DOI] [PubMed] [Google Scholar]
- 13. Tatusov RL, Koonin EV, Lipman DJ. 1997. A genomic perspective on protein families. Science 278:631–637 [DOI] [PubMed] [Google Scholar]
- 14. Wang PW, Chu L, Guttman DS. 2004. Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. J. Bacteriol. 186:400–410 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Yoon SS, et al. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev. Cell 3:593–603 [DOI] [PubMed] [Google Scholar]